Skip to main content Scroll Top

Actualités

  • Accueil
  • Alzheimer
  • A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
Posts les plus vus
Clear Filters
‘Beyond-the-brain’ strategy: a new photobiomodulation technique produces a neuroprotective effect in a mouse model of Alzheimer’s disease by synergistic mechanisms when targeting brain and guts
10 septembre 2019
Alzheimer’s disease and gut microbiota: a potential for prevention and treatment
2 juillet 2019
L’effet neuroprotecteur d’une nouvelle technologie de photobiomodulation réduit la dysbiose du microbiote chez le modèle murin Aβ25-35
30 janvier 2019
1 novembre 2022

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

Read the article

Blivet G, Relano-Gines A, Wachtel M, Touchon J.

J Alzheimers Dis. 2022;90(2):811-822. doi: 10.3233/JAD-220467.

PMID: 36189591 Clinical Trial.

Partagez cet article